Symptoms and Disease Progression of PADMAL
At a Glance
PADMAL often begins with brainstem symptoms such as slurred speech and recurrent small strokes, but progression is highly variable. MRI changes may appear before symptoms and do not reliably predict daily function, so ongoing clinical monitoring is important.
Because PADMAL is a progressive condition, understanding how symptoms typically unfold can help you and your family prepare for the future. While every person’s journey is different, the disease generally follows a pattern that starts in the brainstem and gradually involves more of the brain [1][2].
It is important to know that radiological progression—the changes seen on an MRI—often happens before you feel new symptoms [1]. However, an increase in spots on an MRI does not perfectly predict your day-to-day functional ability, and clinical monitoring is just as important as the scans.
Early Brainstem Symptoms
The earliest signs of PADMAL usually relate to the pons, the part of the brainstem that serves as a major “highway” for signals traveling between your brain and the rest of your body [3]. Most patients experience their first noticeable symptoms between the ages of 30 and 50 [1].
Dysarthria: The Most Common Early Sign
The most frequently reported early symptom is dysarthria [1]. In the context of PADMAL, this is not a problem with understanding language or finding words; rather, it is a physical difficulty in moving the muscles used for speech [3].
- Your speech may sound slurred, slow, or mumbled.
- You may feel that your tongue or jaw is “heavy” or lacks coordination.
- The severity can fluctuate, sometimes appearing suddenly during a small stroke and then partially improving [1].
Recurrent Small Strokes
Many patients experience what doctors call “stuttering” symptoms—small, recurrent strokes (or lacunar infarcts) [1][4]. Because these strokes affect very tiny areas in the pons, they may cause specific, localized issues such as:
- Sudden, temporary weakness in one arm or leg.
- Brief periods of double vision or dizziness.
- A sense of “clumsiness” that comes and goes [4].
Note: Any sudden new or worsening weakness, numbness, speech change, vision change, or imbalance—even if it seems mild or goes away quickly—is a medical emergency and requires immediate evaluation, usually by calling emergency services.
Potential Secondary Progression
As PADMAL advances, the damage often moves from the pons to the supratentorial region—the larger, upper part of the brain [1][2]. While the progression described below has been reported in small families and case series, it is not a predictable or inevitable sequence for everyone.
Cognitive Changes
When the small vessel damage affects the white matter (the brain’s communication wiring) in the upper brain, it can lead to vascular cognitive impairment [1]. In some cases, this may progress to dementia, but this is highly variable. PADMAL-related cognitive decline typically starts with:
- Executive Dysfunction: Difficulty planning, organizing, or switching between tasks.
- Slower Processing: It may take longer to follow a conversation or react to information.
- Apathy: A decrease in motivation or emotional expressiveness [1][5].
Severe Motor Involvement
In some cases, the accumulation of many small strokes can cause more widespread physical disability. Case reports have documented progression to tetraparesis (weakness in all four limbs) or significant swallowing difficulties (dysphagia) [1][5]. This highlights the importance of working with physical, occupational, and speech therapists early on to maintain strength and adapt to changes.
An Uncertain Timeline
One of the most challenging aspects of a PADMAL diagnosis is the lack of a “typical” timeline. Research shows that progression rates vary significantly [1]:
- Individual Variation: Some patients show changes on MRIs over just six months, while others remain relatively stable for years [3][5].
- Family Differences: Even within the same family (people with the exact same genetic mutation), one person may have severe symptoms while another has very mild ones [6][5].
- No Standard Scores: Currently, there are no validated prognostic scores (tools to predict the future) or reliable survival estimates for PADMAL [1][5].
Because there is no “standard” path, your care team will focus on your specific symptoms and MRI findings to guide your management. Monitoring these changes over time is the best way to understand how PADMAL is behaving in your specific case [7].
Common questions in this guide
What is the first symptom of PADMAL?
Can PADMAL cause small strokes that come and go?
Do worsening MRI findings mean my PADMAL symptoms will worsen right away?
How quickly does PADMAL progress?
Can PADMAL affect thinking, movement, or swallowing?
When should I seek emergency help for PADMAL symptoms?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my most recent MRI, is the damage still primarily in my pons, or is there evidence of 'supratentorial' involvement in the rest of my brain?
- 2.How do you distinguish between a new small stroke and the natural progression of my existing PADMAL lesions?
- 3.What specific motor or cognitive assessments should we do periodically to track my progression?
- 4.Are my symptoms typical for my age and the specific COL4A1 mutation I have?
- 5.If I develop swallowing difficulties alongside my slurred speech, what specialists should be added to my care team?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (7)
- 1
Pontine autosomal dominant microangiopathy with leukoencephalopathy: Col4A1 gene variants in the original family and sporadic stroke.
Roos J, Müller S, Giese A, et al.
Journal of neurology 2023; (270(5)):2631-2639 doi:10.1007/s00415-023-11590-9.
PMID: 36786861 - 2
'Raisin bread sign' feature of pontine autosomal dominant microangiopathy and leukoencephalopathy.
Kikumoto M, Kurashige T, Ohshita T, et al.
Brain communications 2023; (5(6)):fcad281 doi:10.1093/braincomms/fcad281.
PMID: 37953842 - 3
Recurrent Pontine Strokes in a Young Male.
Grobe-Einsler M, Urbach H, Paus S
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2020; (29(12)):105386 doi:10.1016/j.jstrokecerebrovasdis.2020.105386.
PMID: 33254373 - 4
A patient with pontine autosomal dominant microangiopathy and leukoencephalopathy caused by a de novo 3' untranslated region mutation of COL4A1 gene: case report and literature review.
Xie F, Li S, Hu X, Li W
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(6)):2833-2838 doi:10.1007/s10072-025-08025-w.
PMID: 39976879 - 5
A Novel Mutation in COL4A1 Gene in a Chinese Family with Pontine Autosomal Dominant Microangiopathy and Leukoencephalopathy.
Li Q, Wang C, Li W, et al.
Translational stroke research 2022; (13(2)):238-244 doi:10.1007/s12975-021-00926-0.
PMID: 34415564 - 6
Cervical Spinal Involvement in a Chinese Pedigree With Pontine Autosomal Dominant Microangiopathy and Leukoencephalopathy Caused by a 3' Untranslated Region Mutation of COL4A1 Gene.
Zhao YY, Duan RN, Ji L, et al.
Stroke 2019; (50(9)):2307-2313 doi:10.1161/STROKEAHA.119.024875.
PMID: 31366314 - 7
Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.
Mancuso M, Arnold M, Bersano A, et al.
European journal of neurology 2020; (27(6)):909-927 doi:10.1111/ene.14183.
PMID: 32196841
This page explains possible PADMAL symptoms and variable progression for informational purposes only; it does not replace medical advice or predict your individual course. Ask your neurologist about changing symptoms or MRI findings, and seek emergency care for sudden stroke-like symptoms.
Get notified when new evidence is published on Pontine autosomal dominant microangiopathy with leukoencephalopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.